Search

Your search keyword '"Sonia Yip"' showing total 4 results
Start Over Author "Sonia Yip" Journal journal of thoracic oncology
4 results on '"Sonia Yip"'

1. FP07.05 DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial

Author

Anne Tsao, Z. Sun, Hedy L. Kindler, Nick Pavlakis, Patrick M. Forde, Peey-Sei Kok, A. Bricker, S.S. Ramalingam, Valsamo Anagnostou, K. Ford, Martin R. Stockler, Brett G.M. Hughes, Alistair M. Cook, Sonia Yip, K. Fitzpatrick, Willem Joost Lesterhuis, Christopher L. Brown, Marjorie G. Zauderer, D. Marinucci, Anna K. Nowak, Kenneth J. O'Byrne, Julie R. Brahmer, and M. Oostendorp

Subjects
Pulmonary and Respiratory Medicine, First line treatment, Chemotherapy, medicine.medical_specialty, Durvalumab, Oncology, Pleural mesothelioma, business.industry, medicine.medical_treatment, medicine, Radiology, business
Published
2021

2. OA08.02 DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result

Author

Wei-Sen Lam, Deme Karikios, Peey-Sei Kok, Chris Karapetis, Willem Joost Lesterhuis, Karen Briscoe, Brett G.M. Hughes, Martin R. Stockler, S. Kao, Christopher L. Brown, Sonia Yip, Thomas John, Nick Pavlakis, Anna K. Nowak, and Kenneth J. O'Byrne

Subjects
0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Durvalumab, business.industry, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Mesothelioma, First line chemotherapy, business
Published
2018

3. P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In

Author

Peey-Sei Kok, Sonia Yip, Mark Donoghoe, Martin R. Stockler, Willem Joost Lesterhuis, Wei-Sen Lam, Anna K. Nowak, and Ann Livingstone

Subjects
0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Durvalumab, business.industry, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Mesothelioma, First line chemotherapy, business
Published
2017

4. P2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

Author

Nick Pavlakis, Peey-Sei Kok, Ben Solomon, Stephen Q. Wong, Martin R. Stockler, Sarah-Jane Dawson, Sonia Yip, Christopher L. Brown, and Ann Livingstone

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, EGFR T790M, T790M, Gefitinib, Internal medicine, Mutation (genetic algorithm), medicine, Physical therapy, In patient, Osimertinib, business, medicine.drug
Published
2017

Catalog

Books, media, physical & digital resources
See catalog results